Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Want to be part of shaping our research and services?

CliniKids is committed to involving consumers and the community in all aspects of our research and service delivery. One way we do this is by providing the opportunity for consumers and community members to contribute through our community reference groups.

News & Events

Communication tools

For Speech Pathology Week, we asked our speech pathologists to share their favourite resource/s and how they like to use it.

News & Events

Welcome Kandice!

CliniKids is excited to welcome Dr Kandice Varcin to the team as part of a new partnership between The Kids Research Institute Australia and Griffith University.

News & Events

Joondalup clinic news

CliniKids’ new clinic in the Joondalup area is coming along nicely and is on track to open around the middle of the year.

Unsubscribe Successful

You're now removed from all The Kids Research Institute Australia marketing email lists

Research

Skin Infections

Our skin, the body’s largest organ, protects us and maintains overall health. Untreated recurring skin infections like impetigo and scabies severely impact children. The Kids is at the forefront of combatting skin infections, particularly within remote Aboriginal communities experiencing some of the world’s highest rates.

Research

Boosting the influenza vaccine schedule in children with cancer: a prospective open-label study

Current immunization guidelines recommend one dose of influenza vaccine for children aged ≥9 years and two doses for younger or vaccine-naïve children. However, children receiving chemotherapy have an attenuated immune response. We performed a prospective open-label study in children undergoing treatment for cancer at Perth Children's Hospital, Western Australia, to examine the safety and efficacy of a boosted influenza schedule.

Research

Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age

We assessed the impact of maternally derived pertussis antibodies on infant responses to a 2 + 1 vaccine schedule (6 weeks, 12 weeks, and 12 months). Infants with baseline antibodies showed lower IgG responses following the primary vaccination series, but this did not impair booster responses at 4 years of age.

Research

Movement difficulties in children with neurodevelopmental disorders: considering a transdiagnostic approach to classification

Children with neurodevelopmental disorders often experience difficulties in acquiring and executing movement skills. Although the motor profiles of neurodivergent children frequently overlap, rigid conceptual distinctions between diagnostic labels have been imposed by traditional categorical approaches to taxonomy. An alternative transdiagnostic approach is proposed to better represent the similarities between presentations.

Research

Prioritizing high-risk populations for soil-transmitted helminth control in the Western Pacific Region

To achieve targets set within the 2030 Sustainable Development Agenda and the 2021–2030 Neglected Tropical Diseases (NTD) Roadmap, the World Health Organization identify the need for improved data analytics to inform NTD control programs.